FROM SEED TO HEALTH

Building Europe's Cannabis Infrastructure

Building Europe's Cannabis Infrastructure

Canna Capital Group is a fully integrated medical cannabis infrastructure platform at the intersection of pharmaceutical precision, certified production standards, and strategic investments. 

Canna Capital Group is a fully integrated medical cannabis infrastructure platform at the intersection of pharmaceutical precision, certified production standards, and strategic investments. 

Capabilities

Swiss quality throughout the medical cannabis value chain.

Swiss quality throughout the medical cannabis value chain.

We operate across the entire cannabis value chain: from genetics and cultivation to licensing, pharmaceutical infrastructure, and EU-wide distribution. Our vertically integrated model ensures quality, compliance and scalable growth at every stage.

We operate across the entire cannabis value chain: from genetics and cultivation to licensing, pharmaceutical infrastructure, and EU-wide distribution. Our vertically integrated model ensures quality, compliance and scalable growth at every stage.

  • High-quality farming

    Our Swiss partner farms produce the finest THC & CBD-rich crops for medical and recreational use, following strict standards and sustainable practices. Trust us for premium, top-quality THC & CBD products.

  • Medical Product Development

    From medical to cosmetic applications, our experts develop safe and effective THC & CBD products. Experience the therapeutic potential of THC & CBD with our scientifically-backed formulations.

  • THC & CBD Products Distribution

    With a strong partner network strategically located across the EU, we are a trusted distributor of THC & CBD products. Enjoy convenient access to a diverse range of THC & CBD offerings for your well-being.

  • Global THC & CBD Trading

    We facilitate international trade and sourcing of THC & CBD raw materials through structured, compliant supply chains. Our global partnerships secure quality materials and consistent availability across markets.

Portfolio

With a strong and connected family

With a strong and connected family

The Canna Capital ecosystem includes a diversified portfolio of companies operating across licensed medical cannabis import, GMP-processing and EU-wide distribution.

The Canna Capital ecosystem includes a diversified portfolio of companies operating across licensed medical cannabis import, GMP-processing and EU-wide distribution.

Businesses

From seed to health

+

Lumen.med

+

TruHC Pharma

+

Pfauen Apotheke Zürich

Lumen.med

Lumen.med provides simple, secure, and doctor-guided access to medical cannabis therapies, offering trusted medical alternatives through a seamless digital experience.

  • Lumen GxP

    Lumen.med provides simple, secure, and doctor-guided access to medical cannabis therapies, offering trusted medical alternatives through a seamless digital experience.

  • TruHC Pharma

    TruHC provides licensed infrastructure for the import, processing, packaging, quality assurance, and distribution of medical cannabis across Germany and the EU.

  • Pfauen Apotheke CH

    As one of Zurich’s earliest medical cannabis pharmacies, Pfauen Apotheke has been a trusted healthcare partner since 1937. It combines pharmaceutical expertise, personal consultation, and verified product quality to support safe and reliable patient care.

Areas of Interest

And a wide array of interests

And a wide array of interests

We count with comprehensive solutions across the entire cannabis industry, integrating cultivation, manufacturing, licensing, clinical operations, and international distribution into a unified ecosystem.

We count with comprehensive solutions across the entire cannabis industry, integrating cultivation, manufacturing, licensing, clinical operations, and international distribution into a unified ecosystem.

Product & Strain Sourcing

Global product and strain sourcing with a focus on premium quality and GACP-controlled cultivation.

Analytics & Quality Control

Certified analytics and quality testing through accredited partner laboratories, followed by batch release.

White Label Solutions

White-label products for partners seeking fast access to available goods under their own brand.

Patient Care

Patient access through proprietary telemedicine platforms and a selected network of partner pharmacies.

Licensed Import

Compliant European import with access to registered strain portfolios upon request.

Processing & Packaging

Flexible GMP-compliant processing, filling and packaging in various unit sizes from 5g to 500g.

Picking & Logistics

Flexible picking, order preparation and logistics solutions to ensure reliable product availability.

Vertical Integration

Customer benefits through deep vertical integration of the medicinal cannabis value chain.

Values

Our Vision & Mission

Our Vision & Mission

We are set to radically change the European medicinal cannabis market.

We are set to radically change the European medicinal cannabis market.

Vision

Leading the European Cannabis Healthcare Infrastructure.

Canna Capital Group connects the European medical cannabis market through pharmaceutical infrastructure, making high-quality medical alternatives more accessible.

Vision

Leading the European Cannabis Healthcare Infrastructure.

Canna Capital Group connects the European medical cannabis market through pharmaceutical infrastructure, making high-quality medical alternatives more accessible.

Mission

Our mission is to establish pharmaceutical quality standards in the regulated European medical cannabis market.

We create access to verified phytopharmaceutical alternatives, ensure consistent quality standards along the value chain, and connect suppliers, partners, and patient care within an integrated infrastructure model.

Since 2022, the group has been building a network of specialized companies that jointly address key market requirements: pharmaceutical quality, regulatory security, operational execution, and access to patient care.

Mission

Our mission is to establish pharmaceutical quality standards in the regulated European medical cannabis market.

We create access to verified phytopharmaceutical alternatives, ensure consistent quality standards along the value chain, and connect suppliers, partners, and patient care within an integrated infrastructure model.

Since 2022, the group has been building a network of specialized companies that jointly address key market requirements: pharmaceutical quality, regulatory security, operational execution, and access to patient care.

Your Gateway to Europe’s Medical Cannabis Market

Your Gateway to Europe’s Medical Cannabis Market

The licensed route from source to pharmacy across Germany and the EU.

The licensed route from source to pharmacy across Germany and the EU.

Let's talk

Canna Capital Group AG

Bahnhofstrasse 3
CH-8808 Pfäffikon

+41(0)6 25 21 01 43

contact@cannacapital.ch

Legal

© Canna Capital Group AG

a web by mimosa